Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

Medicare trust fund faces depletion by 2029, but avoids triggering IPAB

The Medicare Hospital Trust Fund is now projected to run out of money by 2029, one year later than in the 2016 report from Medicare Boards of Trustees. As Kaiser Health News explains, the forecast means the Independent Payment Advisory Board (IPAB) won’t be triggered.

Thumbnail

Hospitals remain opposed to Senate healthcare bill; AMA sees slight improvement

Whenever Republicans in the House or Senate have released a new version of an Affordable Care Act (ACA) replacement plan in 2017, healthcare industry reaction has been almost uniformly negative. The same can largely be said for the newest version of the Better Care Reconciliation Act (BCRA), with the notable exception of the American Medical Association (AMA) when it comes to two provisions. 

Thumbnail

5 things to know about 2018 physician fee schedule, OPPS proposed rules

CMS has released its proposed rules for the 2018 Physician Fee Schedule (PFS), Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System, with the biggest change being halving the Medicare reimbursement for off-campus services.

DWK Life Sciences (formerly DURAN Group) launches a web app. for laboratory labels

DWK Life Sciences GmbH has launched a new web based application to make designing and printing laboratory labels quick and simple: DURAN® Label Creator web app.New DURAN® YOUTILITY labels supplied in a printer ready A4 sheet format accompany the new app.

Mount Sinai Health System Named 2017 Most Wired

Mount Sinai Health System has been named among “Health Care’s Most Wired®,” according to 2017 survey results released this week by the American Hospital Association’s (AHA) Health Forum, and published in the July issue of Hospitals & Health Networks (H&HN).

Thumbnail

House’s HHS budget defies Trump on NIH funding, keeps ONC cuts

President Donald Trump had proposed a 16 percent cut across HHS in his budget blueprint for fiscal year 2018, but the Republican majority on the House Appropriations Committee added $14.5 billion over his request in its own budget proposal released on July 12.

Thumbnail

Fake clinics, unnecessary opioid prescriptions involved in $1.3B fraud crackdown

The U.S. Department of Justice charged 412 people, including 56 doctors, for allegedly participated in false billing schemes netting $1.3 billion, with many cases involving prescriptions of opioids or other narcotics.

Abbott, Bigfoot Biomedical partner to offer diabetes management

Abbott Laboratories and Bigfoot Biomedical have partnered to develop diabetes management systems by integrating Abbott’s FreeStyle Libre glucose sensing technology with Bigfoot’s insulin delivery solutions.

Displaying 4441 - 4448 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup